New research finds lung cancer risk drops substantially within five years of quitting

May 29, 2018, Vanderbilt University Medical Center

Just because you stopped smoking years ago doesn't mean you're out of the woods when it comes to developing lung cancer. That's the "bad" news. The good news is your risk of lung cancer drops substantially within five years of quitting.

These are the main findings of a new analysis of the landmark Framingham Heart Study by researchers at Vanderbilt University Medical Center published May 16 by the Journal of the National Cancer Institute.

"If you smoke, now is a great time to quit," said first author Hilary Tindle, MD, MPH, the William Anderson Spickard Jr., MD Professor of Medicine at the Vanderbilt University School of Medicine and director of the Vanderbilt Center for Tobacco, Addiction and Lifestyle.

"The fact that risk drops relatively quickly after quitting smoking, compared to continuing smoking, gives new motivation," she said.

Tindle and her colleagues examined the health records of residents of Framingham, Massachusetts, who have been followed for decades by the Framingham Heart Study.

The study, which is supported by the National Heart, Lung, and Blood Institute, helped establish and high cholesterol as key risk factors for cardiovascular disease. But it also tracked cancer outcomes.

The current study looked at 8,907 participants who had been followed for 25 to 34 years. During this period, 284 lung cancers were diagnosed, nearly 93 percent of which occurred among , those who had smoked at least a pack of cigarettes a day for 21 years or more.

Five years after quitting, the risk of developing lung cancer in former heavy smokers dropped by 39 percent compared to current smokers, and continued to fall as time went on. Yet even 25 years after quitting, their lung-cancer risk remained over threefold higher compared to people who had never smoked.

The Framingham study is unique because it asked people about their smoking every two to four years, and could account for increases or decreases in smoking over time.

Current federal guidelines, which mandate insurance coverage of for current and former smokers, exclude those who haven't smoked for 15 years or more. Yet four of 10 cancers in heavy smokers in the current study occurred more than 15 years after they quit.

Further study is warranted to determine whether extending the cut-off point for mandated screening would be cost-effective and save lives, the researchers concluded.

"While the importance of smoking cessation cannot be overstated, former heavy smokers need to realize that the risk of lung cancer remains elevated for decades after they smoke their last cigarette, underscoring the importance of screening," said senior author Matthew Freiberg, MD, MSc, professor of Medicine.

Explore further: Quitting smoking, but not cutting back, linked to better lung health

Related Stories

Quitting smoking, but not cutting back, linked to better lung health

May 22, 2018
Researchers analyzed data collected over 30 years from 3,140 participants in the Coronary Artery Risk Development in Young Adults (CARDIA) study. When they enrolled, participants lived in four U.S. cities—Birmingham, AL, ...

High-nicotine dependent smokers 'less likely' to quit after lung cancer screening

May 21, 2018
Tobacco cessation is considered the single most effective primary prevention strategy for reducing the risk of lung cancer death in patients. Having a better understanding of smokers and their characteristics can help to ...

Risk-based lung cancer screening may save more lives than current USPSTF guidelines

January 2, 2018
Lung cancer screening based on individual risk has the potential to save more lives than current recommendations by the U.S. Preventive Services Task Force (USPSTF). The findings are published in Annals of Internal Medicine.

People with HIV who smoke are more likely to die from lung cancer than from HIV itself

September 18, 2017
People living with HIV who adhere to antiretroviral therapy but smoke cigarettes are around 10 times more likely to die from lung cancer than from HIV itself, according to a study led by researchers at Massachusetts General ...

Smokers who receive CT lung screening are more likely to quit

July 24, 2017
Smokers who undergo a CT scan of their lungs are more likely to quit than those who don't, concludes a trial led by Cardiff University.

A shorter time to the first cigarette of the day is associated with risk of lung cancer

June 19, 2014
Standard markers of nicotine dependency include cigarettes smoked per day, duration of smoking, and cumulative exposure (pack years), but another marker of addiction, time to first cigarette (TTFC) of the day, may also be ...

Recommended for you

'Kiss of death' cancer: How computational geeks may have uncovered a therapy for a deadly disease

June 19, 2018
It's called the 'kiss of death'. Triple negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy. Triple negative breast cancer is aggressive and deadly. Patients ...

Team discovers gene mutations linked to pancreatic cancer

June 19, 2018
Six genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's according to Mayo Clinic research published in the June 19 edition of the JAMA. However, ...

Ovarian cancer cells switched off by 'unusual' mechanism

June 19, 2018
Scientists at the Ovarian Cancer Action Research Centre at Imperial College London have discovered a mechanism that deactivates ovarian cancer cells.

Breast cancer could be prevented by targeting epigenetic proteins, study suggests

June 19, 2018
Researchers at the Princess Margaret Cancer Centre in Toronto have discovered that epigenetic proteins promote the proliferation of mammary gland stem cells in response to the sex hormone progesterone. The study, which will ...

Targeting the engine room of the cancer cell

June 18, 2018
Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug ...

Study suggests well-known growth suppressor actually fuels lethal brain cancers

June 18, 2018
Scientists report finding a potentially promising treatment target for aggressive and deadly high-grade brain cancers like glioblastoma. But they also say the current lack of a drug that hits the molecular target keeps it ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.